Dr. Barbara Marie McManus, MD

Dr. McManus practices at AHN Neurology in Pittsburgh, Pennsylvania.

Dr. McManus' NPI, 1124310701, was assigned on May 13, 2011. Dr. McManus holds Pennsylvania license MD446326.

Dr. McManus' primary practice is AHN Neurology, at 420 E North Ave, Pittsburgh, PA 15212 in Allegheny County. The practice phone is (412) 330-5861.

Dr. McManus' primary practice is AHN Neurology in Pittsburgh, Pennsylvania. Dr. McManus is also affiliated with Allegheny General Hospital. The medical group on file is AHN Primary Care - Family Med Associates at H+W Pavilion Bethel Park. Dmand AI also links Dr. McManus to 4 more hospitals, 2 home health agencies, 2 medical groups, 1 group practice or clinic and 1 therapy and rehab clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McManus practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. McManus' primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. McManus is licensed in Pennsylvania.

CMS data shows 479 Medicare services from Dr. McManus across 5 procedure codes in 2024, for 295 Medicare patients. Medicare paid $45,726 for them. Every service was in an office.

CMS counts 295 Medicare patients who saw Dr. McManus in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.42, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. McManus' median patient age at 74, with 61% women.

In 2024, Dr. McManus wrote 3,544 Medicare Part D claims for 585 patients. 99% of them were for generic drugs. CMS names the drug for 3,423 of them, across 16 drugs with 11 or more claims each, at $92,429 in total drug cost. In 2023, CMS named 2,583 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. McManus for performance year 2024, reported through an alternative payment model (APM). Dr. McManus accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. McManus as offering telehealth.

Dmand AI links 3 papers to Dr. McManus, published from 2013 to 2019. The most frequent topics are Chromosomes, Human, Pair 15 and Prader-Willi Syndrome. Dr. McManus' most frequent co-authors are Merlin G. Butler, MD, PhD, Suzanne B. Cassidy, MD and Daniel J. Driscoll, MD, PhD.

CMS Open Payments shows 24 general payments to Dr. McManus from 6 drug and device companies from 2017 to 2019. Food and beverage make up the largest share, 92% of the total. Allergan Inc. paid the most, $164.